Suzhou Novosense Microelectronics (02676) reports net profit attributable to shareholders of RMB83.6555 million for the first three quarters, turning profitable year-on-year.
Novosense (02676) announced that for the first three quarters of 2026, it achieved operating revenue of RMB4.226 billion (the same below), up 78.66% year on year; net profit attributable to shareholders of the listed company was RMB83.6555 million, compared with a loss of RMB140 million in the same period last year; basic earnings per share were RMB0.52.
Suzhou Novosense Microelectronics (02676) announced that for the first three quarters of 2026, it achieved operating revenue of RMB4.226 billion (the same below), up 78.66% year on year; net profit attributable to shareholders of the listed company was RMB83.6555 million, compared with a loss of RMB140 million in the same period last year; basic earnings per share were RMB0.52.
Operating revenue was mainly driven by: (1) On the demand side, benefiting from multiple factors including the recovery in domestic demand, accelerated overseas expansion of solar storage/automotive, and the explosive demand for AI computing infrastructure, customer demand in downstream fields such as automotive electronics, server power supplies, photovoltaic and energy storage, and industrial automation grew rapidly, and the company's shipments of related products increased significantly; (2) On the product side, the company continued to develop products around downstream application scenarios, continuously enriched its semiconductor product and solution matrix, steadily increased the number of product models available for sale, and steadily expanded sales scale; (3) On the market side, the company continued to advance its overseas business strategic expansion, and the revenue contribution from overseas customers steadily increased.
Related Articles

OCUMENSION-B (01477): Fluocinolone acetonide intravitreal implant approved by the National Medical Products Administration for production in mainland China

AI computing power demand overwhelms advanced packaging capacity! Taiwan Semiconductor Manufacturing Co., Ltd. Sponsored ADR (TSM.US) reportedly plans to raise prices by 10-20%, putting cost pressure on NVIDIA Corporation and Apple Inc.

AEON STORES (00984) subsidiary enters into lease agreement for Guangzhou property
OCUMENSION-B (01477): Fluocinolone acetonide intravitreal implant approved by the National Medical Products Administration for production in mainland China

AI computing power demand overwhelms advanced packaging capacity! Taiwan Semiconductor Manufacturing Co., Ltd. Sponsored ADR (TSM.US) reportedly plans to raise prices by 10-20%, putting cost pressure on NVIDIA Corporation and Apple Inc.

AEON STORES (00984) subsidiary enters into lease agreement for Guangzhou property






